Zogenix, Inc.

Quick facts

Marketed products

• Oral Risperidone · Psychiatry/Neurology
  Risperidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain to reduce psychotic symptoms and stabilize mood.
• Risperdal Consta · Psychiatry
  Risperdal Consta is a long-acting injectable antipsychotic that blocks dopamine D2 receptors in the brain to reduce psychotic symptoms.

Phase 1 pipeline

• risperidone-SABER

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Zogenix, Inc. portfolio CI brief
• Zogenix, Inc. pipeline updates RSS